{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:28:37Z","timestamp":1767374917079,"version":"build-2065373602"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["GR-2021-12374872-1"],"award-info":[{"award-number":["GR-2021-12374872-1"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"DOI":"10.1007\/s11481-025-10247-w","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:05:27Z","timestamp":1760087127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytokine Blockade Attenuates Inflammation and Improves Depressive Psychopathology After COVID-19: A Naturalistic Observational Study"],"prefix":"10.1007","volume":"20","author":[{"given":"Mariagrazia","family":"Palladini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia A.","family":"Azzalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Bessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Rovere-Querini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Gennaro","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"10247_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","volume":"141","author":"SH Abbasi","year":"2012","unstructured":"Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S (2012) Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord 141:308\u2013314","journal-title":"J Affect Disord"},{"key":"10247_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/da.20589","volume":"26","author":"S Akhondzadeh","year":"2009","unstructured":"Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi-Rasa S, Raznahan M, Kamalipour A (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26:607\u2013611","journal-title":"Depress Anxiety"},{"key":"10247_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00458","volume":"10","author":"G Arteaga-Henriquez","year":"2019","unstructured":"Arteaga-Henriquez G, Simon MS, Burger B, Weidinger E, Wijkhuijs A, Arolt V, Birkenhager TK, Musil R, Muller N, Drexhage HA (2019) Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium. Front Psychiatry 10:458","journal-title":"Front Psychiatry"},{"key":"10247_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2016.05.047","volume":"202","author":"F Benedetti","year":"2016","unstructured":"Benedetti F, Poletti S, Hoogenboezem TA, Mazza E, Ambree O, de Wit H, Wijkhuijs AJ, Locatelli C, Bollettini I, Colombo C, Arolt V, Drexhage HA (2016) Inflammatory cytokines influence measures of white matter integrity in bipolar disorder. J Affect Disord 202:1\u20139","journal-title":"J Affect Disord"},{"key":"10247_CR5","doi-asserted-by":"publisher","first-page":"e986","DOI":"10.4088\/JCP.16m11310","volume":"78","author":"F Benedetti","year":"2017","unstructured":"Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, de Wit H, Wijkhuijs AJM, Colombo C, Drexhage HA (2017) Higher baseline proinflammatory cytokines mark poor antidepressant response in bipolar disorder. J Clin Psychiatry 78:e986\u2013e993","journal-title":"J Clin Psychiatry"},{"key":"10247_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fpsyt.2020.00071","volume":"11","author":"F Benedetti","year":"2020","unstructured":"Benedetti F, Aggio V, Pratesi ML, Greco G, Furlan R (2020) Neuroinflammation in bipolar depression. Front Psychiatry 11:71","journal-title":"Front Psychiatry"},{"key":"10247_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11481-020-09966-z","volume":"16","author":"F Benedetti","year":"2021","unstructured":"Benedetti F, Mazza M, Cavalli G, Ciceri F, Dagna L, Rovere-Querini P (2021a) Can cytokine blocking prevent depression in COVID-19 survivors?? J Neuroimmune Pharmacol 16:1\u20133","journal-title":"J Neuroimmune Pharmacol"},{"key":"10247_CR8","volume":"18","author":"F Benedetti","year":"2021","unstructured":"Benedetti F, Palladini M, Paolini M, Melloni E, Vai B, De Lorenzo R, Furlan R, Rovere-Querini P, Falini A, Mazza MG (2021b) Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: a multimodal magnetic resonance imaging study. Brain Behav Immun 18:100387","journal-title":"Brain Behav Immun"},{"key":"10247_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.euroneuro.2020.11.009","volume":"42","author":"F Benedetti","year":"2021","unstructured":"Benedetti F, Poletti S, Vai B, Mazza MG, Lorenzi C, Brioschi S, Aggio V, Branchi I, Colombo C, Furlan R, Zanardi R (2021c) Higher baseline interleukin-1beta and TNF-alpha hamper antidepressant response in major depressive disorder. Eur Neuropsychopharmacol 42:35\u201344","journal-title":"Eur Neuropsychopharmacol"},{"key":"10247_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/YIC.0000000000000403","volume":"37","author":"F Benedetti","year":"2022","unstructured":"Benedetti F, Zanardi R, Mazza MG (2022) Antidepressant psychopharmacology: is inflammation a future target? Int Clin Psychopharmacol 37:79\u201381","journal-title":"Int Clin Psychopharmacol"},{"key":"10247_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2022.111534","volume":"326","author":"B Bravi","year":"2022","unstructured":"Bravi B, Bollettini I, Di Pasquasio C, Falini A, Colombo C, Zanardi R, Poletti S, Benedetti F (2022) Brain spectroscopic measures of glutamatergic and neuronal metabolism and glial activation influence white matter integrity in bipolar depression. Psychiatry Res Neuroimaging 326:111534","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10247_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejim.2020.05.021","volume":"76","author":"C Campochiaro","year":"2020","unstructured":"Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N, Tomelleri A, Baldissera E, Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F, Zangrillo A, Tresoldi M, Castagna A, Dagna L, Group T-RS (2020) Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med 76:43\u201349","journal-title":"Eur J Intern Med"},{"key":"10247_CR13","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","volume":"2","author":"G Cavalli","year":"2020","unstructured":"Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, Oltolini C, Castiglioni B, Din T, Boffini C, Tomelleri N, Farina A, Ruggeri N, Rovere-Querini A, Di Lucca P, Martinenghi G, Scotti S, Tresoldi R, Ciceri M, Landoni F, Zangrillo G, Scarpellini A, Dagna P, L (2020) Interleukin-1 blockade with high-dose Anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol 2:e325\u2013e331","journal-title":"Lancet Rheumatol"},{"key":"10247_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/02537176221140557","volume":"45","author":"R Chakravarty","year":"2023","unstructured":"Chakravarty R, Jyani G, Paul S, Mohindra R, Goyal M, Suri V, Bhalla A, Singh SM (2023) Depression, anxiety, and quality of life in patients treated with single infusion Tocilizumab for COVID-19: a follow-up, controlled study. Indian J Psychol Med 45:47\u201352","journal-title":"Indian J Psychol Med"},{"key":"10247_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s13760-021-01748-5","volume":"121","author":"L da Silva Lopes","year":"2021","unstructured":"da Silva Lopes L, Silva RO, de Sousa Lima G, de Araujo Costa AC, Barros DF, Silva-Neto RP (2021) Is there a common pathophysiological mechanism between COVID-19 and depression? Acta Neurol Belg 121:1117\u20131122","journal-title":"Acta Neurol Belg"},{"key":"10247_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"10247_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40263-024-01081-4","volume":"38","author":"R De Lorenzo","year":"2024","unstructured":"De Lorenzo R, Mazza MG, Sciorati C, Leone R, Scavello F, Palladini M, Merolla A, Ciceri F, Bottazzi B, Garlanda C, Benedetti F, Rovere-Querini P, Manfredi AA (2024) Post-COVID trajectory of pentraxin 3 plasma levels over 6 months and their association with the risk of developing post-acute depression and anxiety. CNS Drugs 38:459\u2013472","journal-title":"CNS Drugs"},{"key":"10247_CR18","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/S2665-9913(20)30170-3","volume":"2","author":"G De Luca","year":"2020","unstructured":"De Luca G, Cavalli G, Campochiaro C, Della-Torre E, Angelillo P, Tomelleri A, Boffini N, Tentori S, Mette F, Farina N, Rovere-Querini P, Ruggeri A, D\u2019Aliberti T, Scarpellini P, Landoni G, De Cobelli F, Paolini JF, Zangrillo A, Tresoldi M, Trapnell BC, Ciceri F, Dagna L (2020) GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study. Lancet Rheumatol 2:e465\u2013e473","journal-title":"Lancet Rheumatol"},{"key":"10247_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1136\/annrheumdis-2020-218122","volume":"79","author":"E Della-Torre","year":"2020","unstructured":"Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S, Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, De Cobelli F, Dagna L (2020) Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Ann Rheum Dis 79:1277\u20131285","journal-title":"Ann Rheum Dis"},{"key":"10247_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/nyas.14506","volume":"1486","author":"J Deng","year":"2021","unstructured":"Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, Huang E, Zuo QK (2021) The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci 1486:90\u2013111","journal-title":"Ann N Y Acad Sci"},{"key":"10247_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446\u2013457","journal-title":"Biol Psychiatry"},{"key":"10247_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/acps.12656","volume":"134","author":"P Ellul","year":"2016","unstructured":"Ellul P, Boyer L, Groc L, Leboyer M, Fond G (2016) Interleukin-1 beta-targeted treatment strategies in inflammatory depression: toward personalized care. Acta Psychiatr Scand 134:469\u2013484","journal-title":"Acta Psychiatr Scand"},{"key":"10247_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/YIC.0000000000000356","volume":"36","author":"HY Elnazer","year":"2021","unstructured":"Elnazer HY, Sampson AP, Baldwin DS (2021) Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study. Int Clin Psychopharmacol 36:126\u2013132","journal-title":"Int Clin Psychopharmacol"},{"key":"10247_CR24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mp.2015.168","volume":"21","author":"JC Felger","year":"2016","unstructured":"Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, Miller AH (2016) Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry 21:1358\u20131365","journal-title":"Mol Psychiatry"},{"key":"10247_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/JGP.0b013e318227f4da","volume":"20","author":"C Fields","year":"2012","unstructured":"Fields C, Drye L, Vaidya V, Lyketsos C, Group AR (2012) Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial. Am J Geriatr Psychiatry 20:505\u2013513","journal-title":"Am J Geriatr Psychiatry"},{"key":"10247_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbi.2020.11.024","volume":"92","author":"C Green","year":"2021","unstructured":"Green C, Shen X, Stevenson AJ, Conole ELS, Harris MA, Barbu MC, Hawkins EL, Adams MJ, Hillary RF, Lawrie SM, Evans KL, Walker RM, Morris SW, Porteous DJ, Wardlaw JM, Steele JD, Waiter GD, Sandu AL, Campbell A, Marioni RE, Cox SR, Cavanagh J, McIntosh AM, Whalley HC (2021) Structural brain correlates of serum and epigenetic markers of inflammation in major depressive disorder. Brain Behav Immun 92:39\u201348","journal-title":"Brain Behav Immun"},{"key":"10247_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000470805","volume":"31","author":"E Haroon","year":"2017","unstructured":"Haroon E, Miller AH (2017) Inflammation effects on glutamate as a pathway to neuroprogression in mood disorders. Mod Trends Pharmacopsychiatry 31:37\u201355","journal-title":"Mod Trends Pharmacopsychiatry"},{"key":"10247_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/npp.2016.199","volume":"42","author":"E Haroon","year":"2017","unstructured":"Haroon E, Miller AH, Sanacora G (2017) Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology 42:193\u2013215","journal-title":"Neuropsychopharmacology"},{"key":"10247_CR29","unstructured":"Hayes AF (2017) Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. Guilford Publications, New York"},{"key":"10247_CR30","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/nn.4113","volume":"18","author":"GE Hodes","year":"2015","unstructured":"Hodes GE, Kana V, Menard C, Merad M, Russo SJ (2015) Neuroimmune mechanisms of depression. Nat Neurosci 18:1386\u20131393","journal-title":"Nat Neurosci"},{"key":"10247_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","volume":"7","author":"MI Husain","year":"2020","unstructured":"Husain MI, Chaudhry IB, Khoso AB, Husain MO, Hodsoll J, Ansari MA, Naqvi HA, Minhas FA, Carvalho AF, Meyer JH, Deakin B, Mulsant BH, Husain N, Young AH (2020) Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial. Lancet Psychiatr 7:515\u2013527","journal-title":"Lancet Psychiatr"},{"key":"10247_CR32","doi-asserted-by":"publisher","first-page":"1017e1011","DOI":"10.1016\/j.amjmed.2013.02.037","volume":"126","author":"RL Iyengar","year":"2013","unstructured":"Iyengar RL, Gandhi S, Aneja A, Thorpe K, Razzouk L, Greenberg J, Mosovich S, Farkouh ME (2013) NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am J Med 126:1017e1011\u20131017e1018","journal-title":"Am J Med"},{"key":"10247_CR33","doi-asserted-by":"crossref","unstructured":"Janssen MT, Ramiro S, Mostard RL, Magro-Checa C, Landewe RB (2021) Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study. RMD Open","DOI":"10.1136\/rmdopen-2021-001906"},{"key":"10247_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jad.2019.11.150","volume":"264","author":"L Jones-Brando","year":"2020","unstructured":"Jones-Brando L, Dickerson F, Ford G, Stallings C, Origoni A, Katsafanas E, Sweeney K, Squire A, Khushalani S, Yolken R (2020) Atypical immune response to Epstein-Barr virus in major depressive disorder. J Affect Disord 264:221\u2013226","journal-title":"J Affect Disord"},{"key":"10247_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","volume":"64","author":"YK Kim","year":"2016","unstructured":"Kim YK, Na KS, Myint AM, Leonard BE (2016) The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuropsychopharmacol Biol Psychiatry 64:277\u2013284","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10247_CR36","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O Kohler","year":"2014","unstructured":"Kohler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, Krogh J (2014) Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatr 71:1381\u20131391","journal-title":"JAMA Psychiatr"},{"key":"10247_CR37","first-page":"4195","volume":"55","author":"CA Kohler","year":"2018","unstructured":"Kohler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, de Andrade NQ, Morris G, Fernandes BS, Brunoni AR, Herrmann N, Raison CL, Miller BJ, Lanctot KL, Carvalho AF (2018) Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis. Mol Neurobiol 55:4195\u20134206","journal-title":"Mol Neurobiol"},{"key":"10247_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jad.2022.06.043","volume":"314","author":"M Langhein","year":"2022","unstructured":"Langhein M, Seitz-Holland J, Lyall AE, Pasternak O, Chunga N, Cetin-Karayumak S, Kubicki A, Mulert C, Espinoza RT, Narr KL, Kubicki M (2022) Association between peripheral inflammation and free-water imaging in major depressive disorder before and after ketamine treatment - A pilot study. J Affect Disord 314:78\u201385","journal-title":"J Affect Disord"},{"key":"10247_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","volume":"25","author":"JJ Liu","year":"2020","unstructured":"Liu JJ, Wei YB, Strawbridge R, Bao Y, Chang S, Shi L, Que J, Gadad BS, Trivedi MH, Kelsoe JR, Lu L (2020) Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis. Mol Psychiatry 25:339\u2013350","journal-title":"Mol Psychiatry"},{"key":"10247_CR40","doi-asserted-by":"crossref","unstructured":"Lorkiewicz P, Waszkiewicz N (2021) Biomarkers of post-COVID depression. J Clin Med","DOI":"10.3390\/jcm10184142"},{"key":"10247_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0165-1781(93)90027-E","volume":"49","author":"M Maes","year":"1993","unstructured":"Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49:11\u201327","journal-title":"Psychiatry Res"},{"key":"10247_CR42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new \u20185-HT\u2019 hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 35:702\u2013721","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10247_CR43","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1517\/14728222.2012.718331","volume":"16","author":"M Maes","year":"2012","unstructured":"Maes M, Song C, Yirmiya R (2012) Targeting IL-1 in depression. Expert Opin Ther Targets 16:1097\u20131112","journal-title":"Expert Opin Ther Targets"},{"key":"10247_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.921452","volume":"9","author":"P Mathur","year":"2022","unstructured":"Mathur P, Kottilil S (2022) Immunomodulatory therapies for COVID-19. Front Med 9:921452","journal-title":"Front Med"},{"key":"10247_CR45","doi-asserted-by":"crossref","unstructured":"Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, Ciceri F, group, Rovere-Querini C-BOCS, Benedetti P (2021) F., Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun 94:138\u2013147","DOI":"10.1016\/j.bbi.2021.02.021"},{"key":"10247_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40263-022-00931-3","volume":"36","author":"MG Mazza","year":"2022","unstructured":"Mazza MG, Palladini M, Poletti S, Benedetti F (2022a) Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs 36:681\u2013702","journal-title":"CNS Drugs"},{"key":"10247_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpsychires.2022.08.008","volume":"155","author":"MG Mazza","year":"2022","unstructured":"Mazza MG, Palladini M, Villa G, De Lorenzo R, Rovere Querini P, Benedetti F (2022b) Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue. J Psychiatr Res 155:112\u2013119","journal-title":"J Psychiatr Res"},{"key":"10247_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2021.09.009","volume":"54","author":"MG Mazza","year":"2022","unstructured":"Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F (2022c) Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol 54:1\u20136","journal-title":"Eur Neuropsychopharmacol"},{"key":"10247_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.genhosppsych.2022.12.002","volume":"80","author":"MG Mazza","year":"2023","unstructured":"Mazza MG, Palladini M, Villa G, Agnoletto E, Harrington Y, Vai B, Benedetti F (2023) Prevalence of depression in SARS-CoV-2 infected patients: an umbrella review of meta-analyses. Gen Hosp Psychiatry 80:17\u201325","journal-title":"Gen Hosp Psychiatry"},{"key":"10247_CR50","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00004850-200607000-00005","volume":"21","author":"J Mendlewicz","year":"2006","unstructured":"Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N (2006) Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 21:227\u2013231","journal-title":"Int Clin Psychopharmacol"},{"key":"10247_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:22\u201334","journal-title":"Nat Rev Immunol"},{"key":"10247_CR52","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N Muller","year":"2006","unstructured":"Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11:680\u2013684","journal-title":"Mol Psychiatry"},{"key":"10247_CR53","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","volume":"279","author":"AM Myint","year":"2012","unstructured":"Myint AM (2012) Kynurenines: from the perspective of major psychiatric disorders. FEBS J 279:1375\u20131385","journal-title":"FEBS J"},{"key":"10247_CR54","doi-asserted-by":"publisher","first-page":"12050","DOI":"10.1038\/s41598-018-30487-6","volume":"8","author":"A Ng","year":"2018","unstructured":"Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, Ho RC (2018) IL-1beta, IL-6, TNF- alpha and CRP in elderly patients with depression or alzheimer\u2019s disease: systematic review and meta-analysis. Sci Rep 8:12050","journal-title":"Sci Rep"},{"key":"10247_CR55","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD (2020) Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun 87:901\u2013909","journal-title":"Brain Behav Immun"},{"key":"10247_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2022.12.002","volume":"68","author":"M Paolini","year":"2023","unstructured":"Paolini M, Palladini M, Mazza MG, Colombo F, Vai B, Rovere-Querini P, Falini A, Poletti S, Benedetti F (2023) Brain correlates of subjective cognitive complaints in COVID-19 survivors: a multimodal magnetic resonance imaging study. Eur Neuropsychopharmacol 68:1\u201310","journal-title":"Eur Neuropsychopharmacol"},{"key":"10247_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00423","volume":"10","author":"AJ Perrin","year":"2019","unstructured":"Perrin AJ, Horowitz MA, Roelofs J, Zunszain PA, Pariante CM (2019) Glucocorticoid resistance: is it a requisite for increased cytokine production in depression?? A systematic review and meta-analysis. Front Psychiatry 10:423","journal-title":"Front Psychiatry"},{"key":"10247_CR58","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s40121-023-00871-5","volume":"12","author":"L Piemonti","year":"2023","unstructured":"Piemonti L, Landoni G, Voza A, Puoti M, Gentile I, Coppola N, Nava S, Mattei A, Marinangeli F, Marchetti G, Bonfanti P, Mastroianni CM, Bassetti M, Crisafulli E, Grossi PA, Zangrillo A, Desai A, Merli M, Foggia M, Carpano M, Schiavoni L, Monforte DA, Bisi A, Russo L, Busti G, Rovelli F, Perrotta C, Goisis E, Gavioli G, Toya EM, De Pizzol S, Mantelli M, Allegretti F, Minnella M (2023) Efficacy and safety of reparixin in patients with severe COVID-19 pneumonia: a phase 3, randomized, double-blind placebo-controlled study. Infect Dis Ther 12:2437\u20132456","journal-title":"Infect Dis Ther"},{"key":"10247_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pscychresns.2019.01.009","volume":"285","author":"S Poletti","year":"2019","unstructured":"Poletti S, Leone G, Hoogenboezem TA, Ghiglino D, Vai B, de Wit H, Wijkhuijs AJM, Locatelli C, Colombo C, Drexhage HA, Benedetti F (2019) Markers of neuroinflammation influence measures of cortical thickness in bipolar depression. Psychiatry Res Neuroimaging 285:64\u201366","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10247_CR60","doi-asserted-by":"publisher","first-page":"590095","DOI":"10.3389\/fpsyt.2020.590095","volume":"11","author":"S Poletti","year":"2020","unstructured":"Poletti S, Mazza MG, Vai B, Lorenzi C, Colombo C, Benedetti F (2020) Proinflammatory cytokines predict brain metabolite concentrations in the anterior cingulate cortex of patients with bipolar disorder. Front Psychiatry 11:590095","journal-title":"Front Psychiatry"},{"key":"10247_CR61","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jpsychires.2021.05.071","volume":"140","author":"S Poletti","year":"2021","unstructured":"Poletti S, Mazza MG, Calesella F, Vai B, Lorenzi C, Manfredi E, Colombo C, Zanardi R, Benedetti F (2021a) Circulating inflammatory markers impact cognitive functions in bipolar depression. J Psychiatr Res 140:110\u2013116","journal-title":"J Psychiatr Res"},{"key":"10247_CR62","doi-asserted-by":"crossref","unstructured":"Poletti S, Palladini M, Mazza MG, De Lorenzo R, group C-BOCS, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F (2021b) Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci","DOI":"10.1007\/s00406-021-01346-9"},{"key":"10247_CR63","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00406-021-01346-9","volume":"272","author":"S Poletti","year":"2022","unstructured":"Poletti S, Palladini M, Mazza MG, De Lorenzo R, group C-BOCS, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F (2022) Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci 272:773\u2013782","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10247_CR64","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbi.2024.02.019","volume":"118","author":"S Poletti","year":"2024","unstructured":"Poletti S, Zanardi R, Mandelli A, Aggio V, Finardi A, Lorenzi C, Borsellino G, Carminati M, Manfredi E, Tomasi E, Spadini S, Colombo C, Drexhage HA, Furlan R, Benedetti F (2024) Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: safety, efficacy, and immunological biomarkers. Brain Behav Immun 118:52\u201368","journal-title":"Brain Behav Immun"},{"key":"10247_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27:24\u201331","journal-title":"Trends Immunol"},{"key":"10247_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist Infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatr 70:31\u201341","journal-title":"JAMA Psychiatr"},{"key":"10247_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbi.2019.09.016","volume":"83","author":"M Roman","year":"2020","unstructured":"Roman M, Irwin MR (2020) Novel neuroimmunologic therapeutics in depression: a clinical perspective on what we know so far. Brain Behav Immun 83:7\u201321","journal-title":"Brain Behav Immun"},{"key":"10247_CR68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12974-021-02100-7","volume":"18","author":"E Roohi","year":"2021","unstructured":"Roohi E, Jaafari N, Hashemian F (2021) On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos? J Neuroinflammation 18:45","journal-title":"J Neuroinflammation"},{"key":"10247_CR69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jad.2017.10.042","volume":"227","author":"JD Rosenblat","year":"2018","unstructured":"Rosenblat JD, McIntyre RS (2018) Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials. J Affect Disord 227:219\u2013225","journal-title":"J Affect Disord"},{"key":"10247_CR70","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/pcn.13286","volume":"75","author":"S Sakamoto","year":"2021","unstructured":"Sakamoto S, Zhu X, Hasegawa Y, Karma S, Obayashi M, Alway E, Kamiya A (2021) Inflamed brain: targeting immune changes and inflammation for treatment of depression. Psychiatry Clin Neurosci 75:304\u2013311","journal-title":"Psychiatry Clin Neurosci"},{"key":"10247_CR71","doi-asserted-by":"crossref","unstructured":"Savitz J, Yolken RH (2022) Therapeutic implications of the microbial hypothesis of mental illness. Springer","DOI":"10.1007\/7854_2022_368"},{"key":"10247_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.psyneuen.2014.08.002","volume":"50","author":"AM Simanek","year":"2014","unstructured":"Simanek AM, Cheng C, Yolken R, Uddin M, Galea S, Aiello AE (2014) Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents. Psychoneuroendocrinology 50:139\u2013148","journal-title":"Psychoneuroendocrinology"},{"key":"10247_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110391","volume":"111","author":"MS Simon","year":"2021","unstructured":"Simon MS, Schiweck C, Arteaga-Henriquez G, Poletti S, Haarman BCM, Dik WA, Schwarz M, Vrieze E, Mikova O, Joergens S, Musil R, Claes S, Baune BT, Leboyer M, Benedetti F, Furlan R, Berghmans R, de Wit H, Wijkhuijs A, Arolt V, Muller N, Drexhage HA (2021) Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression. Prog Neuropsychopharmacol Biol Psychiatry 111:110391","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10247_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NDT.S385117","volume":"19","author":"MS Simon","year":"2023","unstructured":"Simon MS, Arteaga-Henriquez G, Fouad Algendy A, Siepmann T, Illigens BMW (2023) Anti-inflammatory treatment efficacy in major depressive disorder: a systematic review of meta-analyses. Neuropsychiatr Dis Treat 19:1\u201325","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10247_CR75","doi-asserted-by":"crossref","unstructured":"Simonetti A, Restaino A, Bernardi E, Ferrara OM, Margoni S, D\u2019Onofrio AM, Ranieri F, Janiri D, Galluzzo V, Tosato M, Kotzalidis GD, Landi F, Sani G (2024) Effect of anti-interleukin-6 agents on psychopathology in a sample of patients with post-COVID-19 syndrome: an observational study. Brain Sci","DOI":"10.3390\/brainsci14010047"},{"key":"10247_CR76","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.brainresrev.2011.01.002","volume":"67","author":"A Spooren","year":"2011","unstructured":"Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G, Gerlo S (2011) Interleukin-6, a mental cytokine. Brain Res Rev 67:157\u2013183","journal-title":"Brain Res Rev"},{"key":"10247_CR77","doi-asserted-by":"publisher","first-page":"C205","DOI":"10.1152\/ajpcell.00246.2024","volume":"327","author":"J Steffen","year":"2024","unstructured":"Steffen J, Focken N, Caliskan G (2024) Recognizing depression as an inflammatory disease: the search for endotypes. Am J Physiol Cell Physiol 327:C205\u2013C212","journal-title":"Am J Physiol Cell Physiol"},{"key":"10247_CR78","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1038\/s41380-022-01520-y","volume":"27","author":"AN Tartt","year":"2022","unstructured":"Tartt AN, Mariani MB, Hen R, Mann JJ, Boldrini M (2022) Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications. Mol Psychiatry 27:2689\u20132699","journal-title":"Mol Psychiatry"},{"key":"10247_CR79","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41380-021-01407-4","volume":"27","author":"A Vasupanrajit","year":"2022","unstructured":"Vasupanrajit A, Jirakran K, Tunvirachaisakul C, Solmi M, Maes M (2022) Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis. Mol Psychiatry 27:1350\u20131361","journal-title":"Mol Psychiatry"},{"key":"10247_CR80","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbi.2021.01.035","volume":"94","author":"N Vindegaard","year":"2021","unstructured":"Vindegaard N, Petersen LV, Lyng-Rasmussen BI, Dalsgaard S, Benros ME (2021) Infectious mononucleosis as a risk factor for depression: a nationwide cohort study. Brain Behav Immun 94:259\u2013265","journal-title":"Brain Behav Immun"},{"key":"10247_CR81","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1038\/srep04530","volume":"4","author":"X Wang","year":"2014","unstructured":"Wang X, Zhang L, Lei Y, Liu X, Zhou X, Liu Y, Wang M, Yang L, Zhang L, Fan S (2014) Meta-analysis of infectious agents and depression. Sci Rep 4:4530","journal-title":"Sci Rep"},{"key":"10247_CR82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2019.02.021","volume":"79","author":"L Wang","year":"2019","unstructured":"Wang L, Wang R, Liu L, Qiao D, Baldwin DS, Hou R (2019) Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: a systematic review and meta-analysis. Brain Behav Immun 79:24\u201338","journal-title":"Brain Behav Immun"},{"key":"10247_CR83","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41380-019-0471-8","volume":"25","author":"GM Wittenberg","year":"2020","unstructured":"Wittenberg GM, Stylianou A, Zhang Y, Sun Y, Gupta A, Jagannatha PS, Wang D, Hsu B, Curran ME, Khan S, Consortium MRCI, Chen G, Bullmore ET, Drevets WC (2020) Effects of immunomodulatory drugs on depressive symptoms: a mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders. Mol Psychiatry 25:1275\u20131285","journal-title":"Mol Psychiatry"},{"key":"10247_CR84","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/npp.2011.277","volume":"37","author":"PA Zunszain","year":"2012","unstructured":"Zunszain PA, Anacker C, Cattaneo A, Choudhury S, Musaelyan K, Myint AM, Thuret S, Price J, Pariante CM (2012) Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 37:939\u2013949","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-025-10247-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-025-10247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:03:27Z","timestamp":1760090607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-025-10247-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10247"],"URL":"https:\/\/doi.org\/10.1007\/s11481-025-10247-w","relation":{},"ISSN":["1557-1904"],"issn-type":[{"type":"electronic","value":"1557-1904"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent to participate in the study was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All procedures involving human patients were approved by Ethics Committee of San Raffaele Hospital (COVID-BioB protocol NCT04318366).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"86"}}